Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Trump Economic Revival: Key Policies and Impact...
By
João L. Carapinha
January 23, 2026
Trump's Davos 2026 Economic Revival: Claimed Policy Impacts and Metrics In his special address at the World Economic Forum's Annual Meeting 2026 in Davos, Switzer...
EU Medicine Authorizations 2025: A Milestone for Innovation and Accessibility
FDA Updates Labeling on Febrile Seizure Risks in Influenza Vaccine for Children
Guiding Principles for Ethical AI Integration in Drug Development
Obesity Medication Guidelines: Evidence-Based Approaches to Effective Treatment
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
Johnson & Johnson’s Medicine Access Agreement: Paving the Way for ...
NICE Endorses Natalizumab RRMS Treatment Expansion for Refractory Cases
Bausch Health’s Strategic Growth in Latin American Pharmaceuticals Thro...
Johnson & Johnson’s EMA Application for Teclistamab Daratumumab Th...
Childhood Immunization Reforms: Aligning U.S. Schedules with Global Standards
Accelerating Tec-Dara Multiple Myeloma Therapy Review: A Game Changer for Pat...
AKEEGA BRCA2 Approval: Landmark FDA Decision for Precision Therapy in Aggress...
« Previous
1
2
3
4
5
…
48
Next »